ANABV
ANAPTYSBIO, INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- TrendDOWNTREND
5% below its 50-day average.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current FY | — | — | — | $107.7M |
| Next Q | — | — | — | $24.7M |
| Current Q | — | — | — | $22.8M |
| Next FY | — | — | — | $172.9M |
SecBot reports
2 filings · 1 bullish · 0 bearish · 1 neutral- BULLISH COURT-RULINGApr 24, 2026
The Delaware Court of Chancery dismissed Tesaro's anticipatory breach claim against AnaptysBio…
The dismissal strengthens AnaptysBio’s position in ongoing negotiations under the collaboration agreement. Traders should monitor for any renewed termination threats or settlement developments, but…
- NEUTRAL 8-KApr 20, 2026
AnaptysBio completed the spin-off of its biopharma operations into First Tracks Biotherapeutics…
Monitor First Tracks' ability to advance its clinical programs ANB033 and ANB101 without the financial support of the royalty business, and track AnaptysBio's cost structure as a virtual royalty…
All ANABV filing & press-release reports (2)
- COURT-RULING reportApr 24, 2026
- 8-K reportApr 20, 2026